{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3228, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "thesis_headline", "function": "establish_context", "notes": "The slide uses a clean, minimalist layout with a network-style background graphic.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/3", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "cover", "function": "front_matter", "notes": "Includes a molecular visualization of the inhibitor binding to the protein.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/4", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a matrix-like structure to compare drug capabilities against specific clinical requirements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/5", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a human anatomy diagram to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to associated clinical side effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/6", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-6", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "645eb1af-3b23-4bf3-bf6c-a731c328939a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slide 6: Overcoming Kinase Selectivity in NSCLC", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a list of icons to represent key clinical attributes of the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/7", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-7", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "6c9c65e6-1206-45c3-bfc7-f5e5a5a7b47d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slide 7: NVL-520 for ROS1-Positive Advanced NSCLC and other Solid Tumors", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses dot plots for IC50 values and a bar chart for tumor regression, highlighting NVL-520's performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/8", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-8", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "analyze_data", "notes": "The chart on the right uses a logarithmic scale for the Selectivity Index.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/9", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-9", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "cover", "function": "front_matter", "notes": "Includes list of authors and their institutional affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/10", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-10", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines the clinical trial structure, including patient eligibility criteria and study objectives for both phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/11", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-11", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a process-flow style diagram to show how initial cohorts are expanded via back-filling and then filtered into a response-evaluable population.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/12", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-12", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents baseline patient characteristics and prior treatment history for a clinical trial cohort.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/13", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-13", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Data presented at ENA 2022. N=35 patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/14", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-14", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart displays a log-scale y-axis for concentration. The data supports once-daily (QD) dosing based on a 20h half-life.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/15", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-15", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial data presentation for ENA 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/16", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-16", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "b01545f0-fd92-41f4-970e-28b5cb49def6", "evidence": "Slides 6-16 discuss the limitations of current treatments and the potential benefits of Nuvalent's therapies.", "position": 0, "objective": "What is the cost of not developing effective treatments for cancer patients with specific genetic mutations?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart is a classic waterfall plot used in oncology clinical trials to demonstrate drug efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/17", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart is a swimmer plot (often used in oncology to show duration of response/treatment).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/18", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "analyze_data", "notes": "Includes a spider plot (waterfall-like over time) and a bar chart showing allele clearance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/19", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a before-after-during progression (Baseline, 4 weeks, 8 weeks) to visualize drug efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/20", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-style list on the left to describe the patient's treatment history and a before-after image grid on the right to show clinical response.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/21", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": "Slide 22 of a conference presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/22", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/23", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style timeline to represent drug development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/24", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 24, "beatId": "fb539b55-6d05-405d-8cdc-98ff53e69b9f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 24: Nuvalent Pipeline – Ongoing Programs", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "key_messages", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/25", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a combination of scatter plots, bar charts, and a waterfall-style selectivity chart to demonstrate drug efficacy and safety profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/26", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "other", "function": "analyze_data", "notes": "The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/27", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a structured table to define patient eligibility criteria for different cohorts in a clinical trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/28", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "thesis_headline", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/29", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses three distinct chart types to demonstrate drug efficacy and safety profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/30", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ce1e-74cc-9870-b1827d8467a5", "docSlug": "ce894072ac0bdbdb4be0c6e520599e56", "documentTitle": "Nuvalent | Investor Presentation Deck | 31 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_messages", "function": "summarize", "notes": "Slide 31 of a corporate presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ce1e-74cc-9870-b1827d8467a5/31", "deckHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5", "deckAnchorHref": "/decks/019de073-ce1e-74cc-9870-b1827d8467a5#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/54TmSZgDFWsIZ5_mF6e-yggPYNaT0LbSIzFUCA1-2jw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMjMxNzI4OWQzYjA2ZDkzOGE2ODNjMTBiYzBkNDBlMC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/1", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/sSLtp8DN-jJQeH2U518dVN5fOP7-MDkfJ0Qqjml7HEM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMjMxNzI4OWQzYjA2ZDkzOGE2ODNjMTBiYzBkNDBlMC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/zB2UBoe2QYItgtwAkOrUi47FpTHjM8PBSYH5NeGTlkI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMjMxNzI4OWQzYjA2ZDkzOGE2ODNjMTBiYzBkNDBlMC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/AYPTD6nSuNQ5TxfgTOW_uODVGxJmPBnR5LGLaPP4EVc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMjMxNzI4OWQzYjA2ZDkzOGE2ODNjMTBiYzBkNDBlMC9wMDAxLnBuZw" }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/2", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "Includes both stock market data and business financial summary in a side-by-side table format.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/3", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-3", "loopMatches": [ { "to": 4, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "89ac54cf-2ebf-47cf-afab-3bd5b2bbb6bf", "evidence": "The Key Investment Considerations and Organicell Snapshot slides imply the importance of investing in Organicell", "position": 0, "objective": "What are the consequences of not investing in Organicell?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/4", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-4", "loopMatches": [ { "to": 4, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "89ac54cf-2ebf-47cf-afab-3bd5b2bbb6bf", "evidence": "The Key Investment Considerations and Organicell Snapshot slides imply the importance of investing in Organicell", "position": 0, "objective": "What are the consequences of not investing in Organicell?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a timeline-based strategic roadmap to outline short, mid, and long-term business goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/5", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "context", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/6", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a four-column layout to describe the biological composition of each product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/7", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "f9f0edaf-11b1-4262-ae84-385cc67612f9", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Product Overview slide", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 7, "from": 7, "beatId": "5b7c0729-9dd4-465d-9b55-07ff8c57268d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Product Overview slide", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "context", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/8", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a mix of bullet points and checkmarks to categorize technical achievements and market opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/9", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-9", "loopMatches": [ { "to": 10, "from": 9, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "2caaf753-0259-474c-8a9c-81eb03e2958f", "evidence": "The Research Facility and Extracellular Vesicles slides imply an understanding of customer needs", "position": 1, "objective": "What are the needs and pain points of customers in the regenerative medicine space?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "context", "function": "establish_context", "notes": "Includes a scientific diagram illustrating the biogenesis of EVs (exosomes, microvesicles, apoptotic bodies).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/10", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-10", "loopMatches": [ { "to": 10, "from": 9, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "2caaf753-0259-474c-8a9c-81eb03e2958f", "evidence": "The Research Facility and Extracellular Vesicles slides imply an understanding of customer needs", "position": 1, "objective": "What are the needs and pain points of customers in the regenerative medicine space?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "context", "function": "establish_context", "notes": "The slide uses two scientific diagrams to illustrate the biological mechanism and molecular content of exosomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/11", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "product_demo", "function": "present_solution", "notes": "The charts are flow cytometry histograms showing CFSE dilution, a standard assay for cell proliferation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/12", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a before-after-bridge structure to demonstrate therapeutic efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/13", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Includes longitudinal patient data and representative imaging.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/14", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "other", "notes": "The slide uses a grid layout to categorize patent statuses (Patent Pending vs Provisional Patent) for four distinct product lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/15", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "team_bio", "function": "other", "notes": "Includes logos of partner firms at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/16", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 16, "beatId": "4ec6ef95-b676-4aca-9d39-632ebb3823b2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Organicell Team slide", "position": 5, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37", "docSlug": "b2317289d3b06d938a683c10bc0d40e0", "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides", "authorId": "organicell-regenerative-medicine", "authorName": "Organicell Regenerative Medicine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide presents real-time financial data for two publicly traded competitors in the regenerative medicine space.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/17", "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37", "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 17, "beatId": "20125799-9791-4b77-9a79-549794891e0c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "Comparable Investments slide", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/UMf8VdJY4nKjsuCggIbJJm_N-1iqtpp9QcZoGv1QkOQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMzZkMjJjZjAwOTJkODUzY2E4YmUwM2FjZjE0MmZhZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/1", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "07eb7215-f756-4f42-b64c-476595949e4c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide, disclaimer, and agenda to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/mK1iDc-YAWHgKqhtgHZoh_t6IKz4KHkjy90U10oPB8Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMzZkMjJjZjAwOTJkODUzY2E4YmUwM2FjZjE0MmZhZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/GgtAVsJS8_2rfv_2SUhLKkdmbYnQnxNSlh5idD4GJys/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMzZkMjJjZjAwOTJkODUzY2E4YmUwM2FjZjE0MmZhZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/d_Hb2EAKhCITCW3z_wC1SONvoXPRu94uLTL1HEs8qxU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lMzZkMjJjZjAwOTJkODUzY2E4YmUwM2FjZjE0MmZhZS9wMDAxLnBuZw" }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/2", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "07eb7215-f756-4f42-b64c-476595949e4c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide, disclaimer, and agenda to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/3", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "07eb7215-f756-4f42-b64c-476595949e4c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide, disclaimer, and agenda to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/4", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "07eb7215-f756-4f42-b64c-476595949e4c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide, disclaimer, and agenda to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a combination of absolute revenue growth and YoY percentage trends to demonstrate business stabilization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/5", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d6179ae8-467e-461f-b7ac-2fe413b0fa77", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights key takeaways and financial results to establish the need for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/6", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d6179ae8-467e-461f-b7ac-2fe413b0fa77", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights key takeaways and financial results to establish the need for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "other", "function": "establish_context", "notes": "Includes a list of brand ambassadors and a metric regarding their aggregate social media following.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/7", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d6179ae8-467e-461f-b7ac-2fe413b0fa77", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights key takeaways and financial results to establish the need for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/8", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d6179ae8-467e-461f-b7ac-2fe413b0fa77", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights key takeaways and financial results to establish the need for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding non-GAAP measures and continuing operations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/9", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "d6179ae8-467e-461f-b7ac-2fe413b0fa77", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The presentation highlights key takeaways and financial results to establish the need for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart includes a trend line annotation showing a 33% decline from Q3 '21 to Q3 '22.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/10", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 10, "beatId": "f2d61fb7-a30d-4aeb-b2d7-de7ed0f722c3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides an overview of revenue, gross margin, and other financial metrics to show satisfaction with progress.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart displays a dual-axis view of gross margin performance over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/11", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 10, "beatId": "f2d61fb7-a30d-4aeb-b2d7-de7ed0f722c3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides an overview of revenue, gross margin, and other financial metrics to show satisfaction with progress.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a combination of bar (absolute $) and line (percentage) to show trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/12", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 10, "beatId": "f2d61fb7-a30d-4aeb-b2d7-de7ed0f722c3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides an overview of revenue, gross margin, and other financial metrics to show satisfaction with progress.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart highlights a decline in both absolute EBITDA and margin percentage over the two-year period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/13", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 10, "beatId": "f2d61fb7-a30d-4aeb-b2d7-de7ed0f722c3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides an overview of revenue, gross margin, and other financial metrics to show satisfaction with progress.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-cf8a-7550-9708-d5470d449c53", "docSlug": "e36d22cf0092d853ca8be03acf142fae", "documentTitle": "Overstock | Results Presentation Deck | 34 slides", "authorId": "overstock", "authorName": "Overstock", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart combines a bar chart for active customers and a line chart for order frequency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-cf8a-7550-9708-d5470d449c53/14", "deckHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53", "deckAnchorHref": "/decks/019de073-cf8a-7550-9708-d5470d449c53#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 10, "beatId": "f2d61fb7-a30d-4aeb-b2d7-de7ed0f722c3", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation provides an overview of revenue, gross margin, and other financial metrics to show satisfaction with progress.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }